Biomarker Discovery and AI for Precision Oncology
Received Date: Oct 01, 2025 / Published Date: Oct 29, 2025
Abstract
Advanced biomarker strategies are transforming cancer management, enabling early detection and personalized therapies. Non-invasive liquid biopsy techniques, including circulating tumor DNA and extracellular vesicles, are pivotal. Artificial intelligence integrates multi-omics data for biomarker discovery. Proteomics, epigenetics, metabolomics, and somatic mutation analysis provide critical insights. Nanotechnology enhances detection, and specific biomarkers guide immunotherapy, collectively improving diagnostic precision, prognosis, and treatment efficacy in oncology.
Keywords: Liquid Biopsy; Cancer Biomarkers; Personalized Medicine; Extracellular Vesicles; Circulating Tumor DNA; Artificial Intelligence; Proteomics; Epigenetics; Metabolomics; Precision Oncology
Citation: Park N (2025) Biomarker Discovery and AI for Precision Oncology. jabt 16: 808. Doi: 10.4172/2155-9872.1000808
Copyright: © 2025 Naomi Park This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 104
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 78
- PDF downloads: 26
